Complement reversal of immunosuppression induced with plasma of rats infected with Trypanosoma brucei rhodesiense.
Suppression of antibody production by splenic lymphocytes from rats immunized with sheep red blood cells (SRBC) after incubation with plasma from rats infected with Trypanosoma brucei rhodesiense was confirmed. Suppressive activity became evident in plasma after the sixth day of infection and was manifested by reduction in the number of hemolytic Jerne plaques produced by the treated cells. The activity was temporally associated with increased amounts of soluble immune complex (SIC) reduced titers of lytic complement, elevated titers of immunoconglutinin (IK) and anemia. Treatment of suppressive plasma with hemolysin sensitized SRBC alexinated with horse complement to reduce IK did not reduce suppressive activity, and the activity appeared to have been enhanced when the plasma was heated to inactivate the remaining complement (C'). When fresh rat C' was added to the treated cells, the suppression was largely, though not completely, reversed. Treatment of spleen cells with SIC prepared in vitro from bovine serum albumin (BSA) and rabbit antiBSA also suppressed the plaque forming capacity of the cells. Complexes of BSA-antiBSA-C' and complexes of BSA-antiBSA-C'-IK were equally suppressive. Again, addition of fresh C' to cells treated with these complexes largely, though not completely, reversed the suppressive effect on the cells. From the results it is suggested that immunosuppression associated with experimental T. b. rhodesiense infection may be in part a suppression of the capacity of induced lymphocytes to produce antibody. It is possible that the suppression was mediated by SIC present in the plasma of the infected rats and this effect was probably enhanced by reduced levels of complement in the suppressive plasma.
D000818:Animals; D000917:Antibody Formation; D000936:Antigen-Antibody Complex / Q000032:analysis / Q000276:immunology*; D003165:Complement System Proteins / Q000276:immunology*; D006462:Hemolytic Plaque Technique; D007108:Immune Tolerance; D037561:Immunoconglutinins; D007136:Immunoglobulins / Q000032:analysis / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D051381:Rats; D014345:Trypanosoma / Q000276:immunology; D014353:Trypanosomiasis, African / Q000276:immunology*
D000936:Antigen-Antibody Complex; D037561:Immunoconglutinins; D007136:Immunoglobulins; D003165:Complement System Proteins